BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 239.8
- Dividend yield
- –
Brainsway statistics
Financials through Jun 30, 2025, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Brainsway | Industry median |
|---|---|---|
| Market Cap | $469.60M | $230.55M |
| Enterprise Value | $401.69M | $202.97M |
| PE Ratio | 239.80 | 33.40 |
| PS Ratio | 11.45 | 3.11 |
| P/OCF Ratio | 45.60 | 22.35 |
Enterprise value
| Measure | Brainsway | Industry median |
|---|---|---|
| EV / Sales | 9.79 | 2.92 |
| EV / EBITDA | 195.85 | 19.86 |
| EV / EBIT | 288.77 | 24.88 |
Income (trailing twelve months)
| Measure | Brainsway | Industry median |
|---|---|---|
| Revenue | $41.02M | $102.39M |
| Gross Profit | $30.58M | $60.36M |
| Operating Income | $1.39M | -$4.31M |
| Pretax Income | $3.46M | -$2.26M |
| EBITDA | $2.05M | -$1.98M |
| EPS (Diluted) | $0.05 | -$0.07 |
Margins
| Measure | Brainsway | Industry median |
|---|---|---|
| Gross Margin | 74.6% | 55.1% |
| Operating Margin | 3.39% | -6.04% |
| Pretax Margin | 8.43% | -4.11% |
| EBITDA Margin | 5.00% | -2.67% |
Returns
| Measure | Brainsway | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | 1.62% | -9.07% |
Growth
| Measure | Brainsway | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 29.0% | 8.85% |
| Revenue Growth (3Y CAGR) | 11.4% | 7.08% |
| Revenue Growth (5Y CAGR) | 12.2% | 11.8% |
Balance sheet
| Measure | Brainsway | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $67.91M | $37.33M |
| Net Cash (Debt) | $67.91M | $3.92M |
| Net Cash Per Share | $1.73 | $0.28 |
| Working Capital | $63.52M | $54.64M |
Financial position
| Measure | Brainsway | Industry median |
|---|---|---|
| Current Ratio | 3.49 | 2.50 |
| Quick Ratio | 2.66 | 1.54 |
| Interest Coverage | 0.92 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Brainsway | Industry median |
|---|---|---|
| Operating Cash Flow | $10.30M | -$653.46K |
Efficiency
| Measure | Brainsway | Industry median |
|---|---|---|
| Asset Turnover | 0.37 | 0.59 |
| Inventory Turnover | 2.49 | 2.21 |
| Revenue Per Employee | $317.95K | $322.57K |
| Employee Count | 129 | 185 |
Shares
| Measure | Brainsway | Industry median |
|---|---|---|
| Shares Outstanding | 39,165,800 | 44,856,700 |
| Shares Change (YoY) | 2.45% | 3.35% |
| Float | 29,186,300 | 37,097,900 |
| Shares Held by Insiders | 25.5% | 10.6% |
| Shares Held by Institutions | 29.2% | 63.5% |
Taxes
| Measure | Brainsway | Industry median |
|---|---|---|
| Income Tax | $538.00K | $1.52M |
| Effective Tax Rate | 15.6% | 18.6% |
Scores
| Measure | Brainsway | Industry median |
|---|---|---|
| Altman Z-Score | 6.38 | 1.95 |
Calculated by StockData from Brainsway's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.